Aurora Cannabis Focuses On U.K. Medical Cannabis Market, Expands Its Collaboration With Grow Group On Heels Of NASDAQ Transfer
Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) confirmed Thursday its subsidiary Aurora Germany GmbH has extended its collaboration with a United Kingdom-focused biopharmaceutical company Grow Group PLC. The two companies signed a two-year market access services agreement for the U.K.
